Trial Profile
Clinical Trials Insight: 700043056
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 06 Apr 2009
Price :
$35
*
At a glance
- Drugs MDX 1342 (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- Sponsors Medarex
- 06 Apr 2009 New trial record.